Yissum Technology Transfer Announces 15 New Companies
Retrieved on:
星期一, 一月 24, 2022
Transfer, Juice, Hebrew University of Jerusalem, Creative Atlantic Communications, Lipovac, TEL, Exosome, Intel, Creative, WILK, Johnson & Johnson, Novartis, OrCam device, Merck, Solution, ICL, American News Company, Communication, Viral disease, Industry, Therapy, Kitchen, Boston Scientific, Technology, Incubator, COVID, Fine chemical, Yissum Research Development Company of the Hebrew University
TEL AVIV, Israel, Jan. 24, 2022 /PRNewswire/ --Yissum, the Technology Transfer Company of The Hebrew University of Jerusalem, today announced its 2021 Portfolio of 15 promising new companies.
Key Points:
- TEL AVIV, Israel, Jan. 24, 2022 /PRNewswire/ --Yissum, the Technology Transfer Company of The Hebrew University of Jerusalem, today announced its 2021 Portfolio of 15 promising new companies.
- "Yissum has long been considered Israel's leading technology transfer company, but our recent successes along with the unprecedented level of portfolio companies, investment partners, and highly promising early-stage tech serve as a real-life testament to that fact," said Yissum CEO Dr. Itzik Goldwaser.
- Yissum has registered over 10,900+ patents globally; licensed over 1,140+ technologies and has spun out more than 200 companies.
- For further information about Yissum, please contact Molly Livingstone, Director of Creative and Communications at Yissum - Technology Transfer Company of Hebrew University at [email protected] .